๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

8574 A phase II study of combination chemotherapy with capecitabine and cisplatin in patients with metastatic or recurrent head and neck cancer

โœ Scribed by Won, Y.W.; Park, Y.H.; Ahn, M.J.; Park, K.

Book ID
122466320
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
45 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase I/II study of S-1 combined with ca
Phase I/II study of S-1 combined with carboplatin in recurrent and/or metastatic head and neck cancer as outpatient chemotherapy
โœ Akihito Watanabe; Masanobu Taniguchi; Tetsuro Yamashita; Michihiro Ueda; Tatsuya ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 115 KB ๐Ÿ‘ 2 views

## Abstract ## Background. The aims of this study were to determine the recommended dose (RD) in combination chemotherapy of Sโ€1 and carboplatin in recurrent and/or metastatic head and neck cancer (phase I) and to examine response rate and toxicities at RD (phase II). ## Methods. Sโ€1 was given o

A phase II study of piritrexim in combin
A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer
โœ Everett E. Vokes; Isaiah W. Dimery; Charlotte D. Jacobs; Daniel Karp; Arturo Mol ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 468 KB ๐Ÿ‘ 2 views

Thirty patients with recurrent and/or metastatic head and neck cancer were treated with sequentially administered methotrexate (MTX) and piritrexim (PTX). The treatment schedule consisted of intravenous (IV) MTX (50 mg/m') administered on day 1 and oral PTX (75 mg/mz) administered twice daily on day